A study shows gut bacteria can reprogram fat to burn energy, offering new targets for obesity and metabolic disease.

In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as pivotal players, offering new avenues for understanding the fine-tuned ...

Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities. Heterogeneity and drug resistance among tumors pose a serious challenge ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Learn about supplements for energy that are not vitamin D, including B12, iron, CoQ10, and adaptogens that may support stamina and reduce fatigue.

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...